Neuroone Medical Technologies (NMTC) Asset Utilization Ratio (2011 - 2026)
Neuroone Medical Technologies (NMTC) posted Asset Utilization Ratio of 1.14 for Q1 2026, up 26.47% on a QoQ basis from 0.9 in Q4 2025, and up 8.26% year-over-year from 1.05 in Q1 2025.
Neuroone Medical Technologies (NMTC) Asset Utilization Ratio (2011 - 2026) Analysis & Trends
Neuroone Medical Technologies' Asset Utilization Ratio history runs 11 years deep, the most recent figure standing at 1.14 for Q1 2026.
- Quarterly Asset Utilization Ratio rose 8.26% year-over-year to 1.14 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 1.14 (up 8.26% YoY) and the FY2025 annual result came in at 1.13, up 119.63% from the prior year.
- Asset Utilization Ratio was 1.14 for Q1 2026 at Neuroone Medical Technologies, up from 0.9 in the prior quarter.
- Across five years, Asset Utilization Ratio topped out at 1.14 in Q1 2026 and bottomed at 0.01 in Q1 2022.
- A 5-year average of 0.52 and a median of 0.66 in 2024 frame the typical range for Asset Utilization Ratio.
- Annual changes were most pronounced in 2022 — Asset Utilization Ratio sank 30.1% — and 2023, when it soared 1908.19%.
- Neuroone Medical Technologies' Asset Utilization Ratio stood at 0.02 in 2022, then soared by 1704.59% to 0.4 in 2023, then soared by 139.58% to 0.97 in 2024, then fell by 7.11% to 0.9 in 2025, then gained by 26.47% to 1.14 in 2026.
- Business Quant data shows NMTC's Asset Utilization Ratio at 1.14 in Q1 2026, 0.9 in Q4 2025, and 0.84 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Asset Util. (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 0.46 |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 0.54 |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 0.39 |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 0.47 |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 0.47 |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 0.74 |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 0.65 |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 0.57 |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | Neuroone Medical Technologies | 7.99 Mn | 5.19 Mn | 990,264.00 | 1.14 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.14 |
| Dec 31, 2025 | 0.90 |
| Sep 30, 2025 | 0.84 |
| Jun 30, 2025 | 0.87 |
| Mar 31, 2025 | 1.05 |
| Dec 31, 2024 | 0.97 |
| Sep 30, 2024 | 0.67 |
| Jun 30, 2024 | 0.76 |
| Mar 31, 2024 | 0.66 |
| Dec 31, 2023 | 0.40 |
| Sep 30, 2023 | 0.28 |
| Jun 30, 2023 | 0.20 |
| Mar 31, 2023 | 0.08 |
| Dec 31, 2022 | 0.02 |
| Sep 30, 2022 | 0.01 |
| Jun 30, 2022 | 0.01 |
| Mar 31, 2022 | 0.01 |
| Dec 31, 2021 | 0.01 |
| Sep 30, 2021 | 0.02 |
| Jun 30, 2021 | 0.01 |